These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 32780352)

  • 1. Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell Death.
    Liu M; Sui D; Dexheimer T; Hovde S; Deng X; Wang KW; Lin HL; Chien HT; Kweon HK; Kuo NS; Ayoub CA; Jimenez-Harrison D; Andrews PC; Kwok R; Bochar DA; Kuret J; Fortin J; Tsay YG; Kuo MH
    Mol Neurobiol; 2020 Nov; 57(11):4704-4719. PubMed ID: 32780352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperphosphorylated tau aggregation and cytotoxicity modulators screen identified prescription drugs linked to Alzheimer's disease and cognitive functions.
    Liu M; Dexheimer T; Sui D; Hovde S; Deng X; Kwok R; Bochar DA; Kuo MH
    Sci Rep; 2020 Oct; 10(1):16551. PubMed ID: 33024171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer's disease and related tauopathies.
    Moore KBE; Hung TJ; Fortin JS
    Drug Discov Today; 2023 Mar; 28(3):103487. PubMed ID: 36634842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel histone de acetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer's disease model.
    Fan SJ; Huang FI; Liou JP; Yang CR
    Cell Death Dis; 2018 May; 9(6):655. PubMed ID: 29844403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Tau in Various Tauopathies, Treatment Approaches, and Emerging Role of Nanotechnology in Neurodegenerative Disorders.
    Kaur P; Khera A; Alajangi HK; Sharma A; Jaiswal PK; Singh G; Barnwal RP
    Mol Neurobiol; 2023 Mar; 60(3):1690-1720. PubMed ID: 36562884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro aggregation assays using hyperphosphorylated tau protein.
    Sui D; Liu M; Kuo MH
    J Vis Exp; 2015 Jan; (95):e51537. PubMed ID: 25590418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T; Yu JT; Zhu XC; Zhang QQ; Cao L; Wang HF; Tan MS; Gao Q; Qin H; Zhang YD; Tan L
    Neuropharmacology; 2014 Oct; 85():121-30. PubMed ID: 24880087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARN25068, a versatile starting point towards triple GSK-3β/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.
    Demuro S; Sauvey C; Tripathi SK; Di Martino RMC; Shi D; Ortega JA; Russo D; Balboni B; Giabbai B; Storici P; Girotto S; Abagyan R; Cavalli A
    Eur J Med Chem; 2022 Feb; 229():114054. PubMed ID: 34959172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
    Wang JZ; Wang ZH
    Exp Gerontol; 2015 Aug; 68():82-6. PubMed ID: 25777063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures.
    Rankin CA; Sun Q; Gamblin TC
    Neurobiol Dis; 2008 Sep; 31(3):368-77. PubMed ID: 18588978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay.
    Holzer M; Schade N; Opitz A; Hilbrich I; Stieler J; Vogel T; Neukel V; Oberstadt M; Totzke F; Schächtele C; Sippl W; Hilgeroth A
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30213139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration.
    Li HL; Wang HH; Liu SJ; Deng YQ; Zhang YJ; Tian Q; Wang XC; Chen XQ; Yang Y; Zhang JY; Wang Q; Xu H; Liao FF; Wang JZ
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3591-6. PubMed ID: 17360687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease brain contains tau fractions with differential prion-like activities.
    Li L; Shi R; Gu J; Tung YC; Zhou Y; Zhou D; Wu R; Chu D; Jin N; Deng K; Xu J; Gong CX; Iqbal K; Liu F
    Acta Neuropathol Commun; 2021 Feb; 9(1):28. PubMed ID: 33597014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3ζ Mediates Tau Aggregation in Human Neuroblastoma M17 Cells.
    Li T; Paudel HK
    PLoS One; 2016; 11(8):e0160635. PubMed ID: 27548710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice.
    Guo JL; Narasimhan S; Changolkar L; He Z; Stieber A; Zhang B; Gathagan RJ; Iba M; McBride JD; Trojanowski JQ; Lee VM
    J Exp Med; 2016 Nov; 213(12):2635-2654. PubMed ID: 27810929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new non-aggregative splicing isoform of human Tau is decreased in Alzheimer's disease.
    García-Escudero V; Ruiz-Gabarre D; Gargini R; Pérez M; García E; Cuadros R; Hernández IH; Cabrera JR; García-Escudero R; Lucas JJ; Hernández F; Ávila J
    Acta Neuropathol; 2021 Jul; 142(1):159-177. PubMed ID: 33934221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of intracellular tau aggregation is promoted by α-synuclein seeds and provides novel insights into the hyperphosphorylation of tau.
    Waxman EA; Giasson BI
    J Neurosci; 2011 May; 31(21):7604-18. PubMed ID: 21613474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged arsenic exposure increases tau phosphorylation in differentiated SH-SY5Y cells: The contribution of GSK3 and ERK1/2.
    Wisessaowapak C; Visitnonthachai D; Watcharasit P; Satayavivad J
    Environ Toxicol Pharmacol; 2021 May; 84():103626. PubMed ID: 33621689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of tau isoforms with Alzheimer's disease abnormally hyperphosphorylated tau and in vitro phosphorylation into the disease-like protein.
    Alonso AD; Zaidi T; Novak M; Barra HS; Grundke-Iqbal I; Iqbal K
    J Biol Chem; 2001 Oct; 276(41):37967-73. PubMed ID: 11495914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.